MULTIPLE CHOICE: If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one ?

All of the above. Blood sugar is triggered for release using a cascade. Epinephrine binds, G-protein causes AMP -> cAMP formation and phosphorylase is activated. Each step turns on the subsequent step. To block glucose release, inhibiting each step would work.